Donor leukocyte infusions and graft-versus-malignancy.
Antin
Joseph H
JH
Medical Oncology Stem Cell Transplantation Program, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. jantin@partners.org
D006086:Graft vs Host Disease / Q000628:therapy*; D020544:Graft vs Leukemia Effect; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000628:therapy; D017708:Leukocyte Transfusion / Q000379:methods; D019520:Living Donors